Missing/wrong data? Edit Wikidata item
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
scientific article published on 19 August 2020
Author/s
Work details
Publication date:
August 19, 2020
Language:
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.